AC
AVXL icon

AXQ Capital’s Anavex Life Sciences AVXL Stock Holding History

AXQ Capital’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
40,748
+29,327
+257% +$86.8K 0.01% 831
2026
Q1 		$35.1K Sell
11,421
-13,575
-54% -$58.8K ﹤0.01% 949
2025
Q4 		$89K Buy
24,996
+5,895
+31% +$36.1K 0.02% 668
2025
Q3 		$170K Buy
+19,101
New +$194K 0.07% 474
2025
Q2 		– Sell
-17,888
Closed -$153K – 579
2025
Q1 		$153K Buy
+17,888
New +$169K 0.06% 422
2024
Q1 		– Sell
-19,600
Closed -$182K – 620
2023
Q4 		$182K Buy
+19,600
New +$135K 0.05% 544

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AXQ Capital's AVXL Position: Q2 2026 in Review

AXQ Capital increased its Anavex Life Sciences (AVXL) stake by 257% in Q2 2026, buying an estimated $86.8K and bringing the position to 40,748 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #831.

AXQ Capital first reported a position in AVXL in Q4 2023 and has held it in 6 quarters since. The position peaked at $182K in Q4 2023. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • AXQ Capital held 40,748 shares of Anavex Life Sciences worth $106K as of Q2 2026.
  • AXQ Capital bought 29,327 Anavex Life Sciences shares in Q2 2026, an estimated $86.8K.
  • Anavex Life Sciences made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #831 holding.
  • AXQ Capital first reported a position in Anavex Life Sciences in Q4 2023 and has held it in 6 quarters since.
  • AXQ Capital's Anavex Life Sciences position peaked at $182K in Q4 2023.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.